Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
Saved in:
| Title: | Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. |
|---|---|
| Authors: | Ostendorf L; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Division of Rheumatology, Inflammation, Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Zernicke J; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Klotsche J; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Kempkens R; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Beenken AE; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Biesen R; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Cheng Q; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Khodadadi L; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Guerra GM; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Heinrich F; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Durek P; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany., Burmester GR; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Krönke G; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Hiepe F; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Mashreghi MF; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), Berlin, Germany., Alexander T; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany. tobias.alexander@charite.de.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. tobias.alexander@charite.de. |
| Source: | Nature communications [Nat Commun] 2026 Feb 03; Vol. 17 (1), pp. 1312. Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41629292 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ostendorf+L%22">Ostendorf L</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Division of Rheumatology, Inflammation, Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zernicke+J%22">Zernicke J</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Klotsche+J%22">Klotsche J</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kempkens+R%22">Kempkens R</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Beenken+AE%22">Beenken AE</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Biesen+R%22">Biesen R</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cheng+Q%22">Cheng Q</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Khodadadi+L%22">Khodadadi L</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Guerra+GM%22">Guerra GM</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Heinrich+F%22">Heinrich F</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Durek+P%22">Durek P</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Burmester+GR%22">Burmester GR</searchLink>; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Krönke+G%22">Krönke G</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hiepe+F%22">Hiepe F</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Mashreghi+MF%22">Mashreghi MF</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.; German Center for Child and Adolescent Health (DZKJ), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Alexander+T%22">Alexander T</searchLink>; German Rheumatology Research Centre (DRFZ), an Institute of the Leibniz Association, Berlin, Germany. tobias.alexander@charite.de.; Department of Rheumatology and Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. tobias.alexander@charite.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Feb 03; Vol. 17 (1), pp. 1312. <i>Date of Electronic Publication: </i>2026 Feb 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41629292 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-69112-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1312 Titles: – TitleFull: Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ostendorf L – PersonEntity: Name: NameFull: Zernicke J – PersonEntity: Name: NameFull: Klotsche J – PersonEntity: Name: NameFull: Kempkens R – PersonEntity: Name: NameFull: Beenken AE – PersonEntity: Name: NameFull: Biesen R – PersonEntity: Name: NameFull: Cheng Q – PersonEntity: Name: NameFull: Khodadadi L – PersonEntity: Name: NameFull: Guerra GM – PersonEntity: Name: NameFull: Heinrich F – PersonEntity: Name: NameFull: Durek P – PersonEntity: Name: NameFull: Burmester GR – PersonEntity: Name: NameFull: Krönke G – PersonEntity: Name: NameFull: Hiepe F – PersonEntity: Name: NameFull: Mashreghi MF – PersonEntity: Name: NameFull: Alexander T IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 02 Text: 2026 Feb 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |